caspase-3 Antikörper (E-8): sc-7272

caspase-3 Antibody (E-8) is an IgG_2a κ mouse monoclonal caspase-3 antibody (also designated CASP3 antibody or CPP32 antibody) suitable for the detection of the caspase-3 protein of human origin by WB, IP, IF, IHC(P), FCM and ELISA. caspase-3 Antibody (E-8) is available as both the non-conjugated anti-caspase-3 antibody form, as well as multiple conjugated forms of anti-caspase-3 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor^® conjugates. Caspase-3, also known as apopain, SCA-1, Yama and CPP32, is an aspartate-specific cysteine protease that belongs to the ICE subfamily of caspases. Caspase-3 is expressed in cells as an inactive precursor from which the p17 and p11 subunits of the mature caspase-3 are proteolytically generated during apoptosis. The caspase-3 precursor is first cleaved at Asp175-Ser176 to produce the p11 subunit and the p20 peptide. Subsequently, the p20 peptide is cleaved at Asp28-Ser29 to generate the mature p17 subunit. The active caspase-3 enzyme is a heterodimer composed of two p17 and two p11 subunits. At the onset of apoptosis, caspase-3 proteolytically cleaves PARP at an Asp216-Gly217 bond. During the execution of the apoptotic cascade, activated caspase-3 releases SREBP from the membrane of the ER in a proteolytic reaction that is distinct from their normal sterol-dependent activation. Caspase-3 cleaves and activates SREBPs between the basic helix-loop-helix leucine zipper domain and the membrane attachment domain. Caspase-3 also cleaves and activates caspase-6, -7 and -9. The human caspase-3 gene encodes a cytoplasmic protein that is highly expressed in lung, spleen, heart, liver, kidney and cells of the immune system.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

References:

1. Apoptosis-induced release of mature sterol regulatory element-binding proteins activates sterol-responsive genes.  |  Higgins, ME. and Ioannou, YA. 2001. J Lipid Res. 42: 1939-46. PMID: 11734566
2. Apoptosis and proliferation markers in diffusely infiltrating astrocytomas: profiling of 17 molecules.  |  Liu, X., et al. 2006. J Neuropathol Exp Neurol. 65: 905-13. PMID: 16957584
3. A primate-specific acceleration in the evolution of the caspase-dependent apoptosis pathway.  |  Vallender, EJ. and Lahn, BT. 2006. Hum Mol Genet. 15: 3034-40. PMID: 16980329
4. 3-(3,4,5-Trimethoxyphenyl)-1-oxo-2-propene: a novel pharmacophore displaying potent multidrug resistance reversal and selective cytotoxicity.  |  Das, U., et al. 2007. Bioorg Med Chem. 15: 3373-80. PMID: 17383883
5. Alterations in mRNA expression of apoptosis-related genes BCL2, BAX, FAS, caspase-3, and the novel member BCL2L12 after treatment of human leukemic cell line HL60 with the antineoplastic agent etoposide.  |  Floros, KV., et al. 2006. Ann N Y Acad Sci. 1090: 89-97. PMID: 17384250
6. Caspase-3 activation, Bcl-2 contents, and soluble FAS-ligand are not related to the inflammatory marker profile in patients with sepsis and septic shock.  |  Kriebel, F., et al. 2006. Ann N Y Acad Sci. 1090: 168-76. PMID: 17384259
7. Role of ATP in trauma-associated cytokine release and apoptosis by P2X7 ion channel stimulation.  |  Schneider, EM., et al. 2006. Ann N Y Acad Sci. 1090: 245-52. PMID: 17384268
8. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.  |  Nicholson, DW., et al. 1995. Nature. 376: 37-43. PMID: 7596430
9. Caspases: the executioners of apoptosis.  |  Cohen, GM. 1997. Biochem J. 326 (Pt 1): 1-16. PMID: 9337844